or Try an Advanced Search...

    ETF Components for GNOM - Global X Genomics & Biotechnology ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    VCYT B 1.48 4.69
    CRSP D -1.29 4.66
    NTRA A 1.53 4.41
    ARWR D 0.16 4.31
    TECH F 2.77 4.21
    ILMN C 2.13 4.14
    QGEN D 0.48 4.09
    RNA C 0.78 4.06
    BEAM D -1.57 4.03
    A F 2.52 3.93
    BNTX D 2.88 3.83
    BMRN F 0.48 3.71
    ALNY D 0.43 3.71
    RARE F 0.66 3.63
    LEGN D -1.33 3.56
    SRPT F -0.55 3.55
    NTLA F 8.46 3.23
    MRNA F 0.38 3.13
    TXG F 0.38 2.93
    MYGN F 0.46 2.80
    RCKT F 1.30 2.62
    GILD B 1.10 2.17
    CDNA D 0.20 2.13
    VRTX D 0.15 2.09
    VIR F -0.21 1.61
    MRVI F 3.11 1.26
    PACB D 4.07 1.18
    SGMO C 3.53 0.99
    RGNX D -3.79 0.95
    ALLO F 2.44 0.79
    VERV D 3.08 0.74
    FLGT F -0.64 0.73
    SANA F -4.94 0.65
    QURE D 1.49 0.64
    EDIT F -0.83 0.50
    PSTX D 2.57 0.44
    CRBU D 3.32 0.42
    TSVT F 0.96 0.41
    LYEL F -8.83 0.31
    SCLX F -1.17 0.01

    Represented by ETF Holdings

    Keywords: Biotechnology Life Sciences Biology Medicine Biopharmaceutical Cancer Acid Genetics Molecular Biology Clinical Medicine Immune System Disease Gene Therapy In Vitro S&P 500 Applied Genetics Chimeric Antigen Receptor T Cell Gene Expression Genome Genomics
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - General Drug Manufacturers - Major Health Information Services

    Recent News for Global X Genomics & Biotechnology ETF & its Holdings

    Date Stock Title
    Nov 21 TECH Reddit Suffers Second Disruption In Two Days
    Nov 21 TECH IBM Spin-Off Kyndryl Announces $300 Million Buyback: What's Next For KD Stock?
    Nov 21 MRNA Major companies that are also popular short-selling stocks
    Nov 21 LEGN High Growth Tech Stocks in the United States to Watch
    Nov 21 TECH Temu Parent PDD Stock Tumbles After Q3 Profit Miss, Company Cites Intensified Competition and External Challenges
    Nov 21 TECH How To Earn $500 A Month From Intuit Stock Ahead Of Q1 Earnings
    Nov 21 TECH Tesla Registrations Drop By Over 20% In October In EU, Possibly Hindering Its 2024 Global EV Delivery Target
    Nov 21 TECH SpaceX CEO Elon Musk Reveals Technical Glitch That Led Company To Drop Key Objective Of Starship's 6th Test Flight
    Nov 21 TECH Ray Dalio Says Pro-Trump Tech Companies Stand To Gain As Focus Shifts To Deregulation: Here's How Investors Should Brace For Impact
    Nov 21 TECH SafeRent Settles $2.3M Discrimination Lawsuit Over Alleged AI Screening Bias Against Low-Income Renters
    Nov 21 TECH Google's 'Unlawful Behavior' Stifles Market Entry For Rivals: DOJ Says Alphabet Must Sell Chrome To End Search Monopoly
    Nov 21 TECH Tesla Now Allows Users To Report Snow Accumulation, Blocked Stalls And Other Supercharger Issues Ahead Of Winter
    Nov 21 TECH Why SpaceX Opted For Standard Starship Landing Over Elon Musk's Innovative 'Chopsticks' Technique
    Nov 21 TECH Ford's JV Battery Plant In Kentucky Faces Unionization As 'Supermajority' Of Workers Sign Union Authorization Cards, Says UAW
    Nov 21 TECH Nvidia's Blackwell Set To Outpace Hopper? Here's What CEO Jensen Huang Predicts For 2025
    Nov 21 TECH Elon Musk's Neuralink Gets Green Light To Launch Brain Chip Trial In Canada: 'Recruitment Is Now Open'
    Nov 21 TECH Nvidia CEO Jensen Huang Says The Present Time Is 'The Beginnings Of Two Fundamental Shifts In Computing' As Blackwell Powers Explosive AI Demand
    Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
    Nov 21 TECH Nvidia Stock Holding Up Better Than Gary Black's Expectations Amid Blackwell Chip Delays And Q4 Whisper Number Miss: Here's Why
    Nov 20 TECH Nvidia Beats Q3 Revenue, EPS Estimates, Supply Constraints Ding Stock: Huang Says 'Age Of AI Is In Full Steam' (UPDATED)
    The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Biotechnology Genomics
    Back to the Main GNOM Page...